Human placenta-derived cells (PDA-001) for the treatment of moderate-to-severe Crohn's disease: A phase 1b/2a study

Gil Y. Melmed*, William M. Pandak, Kevin Casey, Bincy Abraham, John Valentine, David Schwartz, Dahlia Awais, Issac Bassan, Simon Lichtiger, Bruce Sands, Stephen Hanauer, Robert Richards, Ioannis Oikonomou, Nimisha Parekh, Stephen Targan, Kristine Johnson, Robert Hariri, Steven Fischkoff

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

61 Scopus citations

Fingerprint

Dive into the research topics of 'Human placenta-derived cells (PDA-001) for the treatment of moderate-to-severe Crohn's disease: A phase 1b/2a study'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science